HR 2870
117th Congress
House
Health
Business records
Congressional oversight
Emergency medical services and trauma care
Government information and archives
Government studies and investigations
Health care coverage and access
Health programs administration and funding
Health technology, devices, supplies
Prescription drugs
Public contracts and procurement
Public-private cooperation
Strategic materials and reserves
Essential Medicines Strategic Stockpile Act of 2021
Introduced: April 28, 2021
Introduced by:
Carter, Earl L. "Buddy"
Republican
· Georgia
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 29, 2021
Referred to the Subcommittee on Health.
Apr 28, 2021
Referred to the House Committee on Energy and Commerce.
Apr 28, 2021
Introduced in House
Plain-English summary
Essential Medicines Strategic Stockpile Act of 2021
This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.
Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.
The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2
Cosponsors
1